Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 66772 [2010-27462]

Download as PDF 66772 Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices WReier-Aviles on DSKGBLS3C1PROD with NOTICES Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases (CADET I). Date: November 18–19, 2010. Time: 6 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Keary A Cope, PhD, Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892–7924, (301) 435–2222, copeka@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Common Pathogenetic Mechanisms of Lung Cancer and COPD. Date: November 19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Robert T. Su, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7202, Bethesda, MD 20892–7924, 301–435–0297, sur@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Next Generation Genetic Association Studies. Date: November 19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications, Place: Westin BWI (Baltimore), 1100 Old Elkridge Landing Road, Baltimore, MD 21090. Contact Person: David A Wilson, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892–7924, 301–435–0299, wilsonda2@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 22, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–27319 Filed 10–28–10; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 15:23 Oct 28, 2010 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Dated: October 22, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–27462 Filed 10–28–10; 8:45 am] Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: DEPARTMENT OF HEALTH AND HUMAN SERVICES Time and Date: 10:30 a.m.–12 p.m., November 15, 2010. Place: Teleconference. Status: Open to the public, the toll free dial in number is 1(800)369–1755 with a pass code of 8481618. Purpose: The BSC, OID, shall advise the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, concerning strategies, goals, and priorities for the programs and research within the national centers and monitor the overall strategic direction and focus of OID and the national centers. Matters To Be Discussed: The meeting will involve the presentation of a draft document being developed to advance CDC’s infectious disease priorities. A subsequent meeting to solicit further discussion and input on the document from the board is currently scheduled for December 6, 2010 and will be announced at a future date. Requests for a copy of the draft document may be sent to ddidinput@cdc.gov prior to the teleconference. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, CDC, OID, 1600 Clifton Road, NE., Mailstop D–10, Atlanta, Georgia 30333, telephone (404) 639– 4461. The Director, Management and Analysis Services Office, has been delegated the authority to sign the Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the Sleep Disorders Research Advisory Board. The meetings will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meetings Name of Committee: Sleep Disorders Research Advisory Board. Date: November 12, 2010. Time: 3 p.m. to 5 p.m. Agenda: To discuss sleep research programs and sleep research strategic planning. Public meeting observers should call 1–800–779–2608 to access the teleconference and the observer passcode is 7989226. Public meeting observers should send comments or questions for this meeting to the National Center on Sleep Disorders Research by e-mail mt2d@nih.gov or fax 301– 480–3557. Place: National Institutes of Health, 6701 Rockledge Drive, Suite 10170, Bethesda, MD 20892 (Telephone Conference Call.) Contact Person: Michael J Twery, PhD, Director, National Center on Sleep Disorders Research, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Suite 10038, Bethesda, MD 20892–7952, 301– 435–0199, twerym@nhlbi.nih.gov. Name of Committee: Sleep Disorders Research Advisory Board. Date: December 10, 2010. Time: 8:30 a.m. to 4 p.m. Agenda: To discuss sleep research programs and sleep research strategic planning. Place: National Institutes of Health, Building 31, 31 Center Drive, C–Wing, Conference Room 6, Bethesda, MD 20892. Contact Person: Michael J Twery, PhD, Director, National Center on Sleep Disorders Research, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Suite 10038, Bethesda, MD 20892–7952,301– 435–0199, twerym@nhlbi.nih.gov. Any interested person may file written comments with the committee by E:\FR\FM\29OCN1.SGM 29OCN1

Agencies

[Federal Register Volume 75, Number 209 (Friday, October 29, 2010)]
[Notices]
[Page 66772]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27462]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Time and Date: 10:30 a.m.-12 p.m., November 15, 2010.
    Place: Teleconference.
    Status: Open to the public, the toll free dial in number is 
1(800)369-1755 with a pass code of 8481618.
    Purpose: The BSC, OID, shall advise the Secretary, Department of 
Health and Human Services; the Director, CDC; the Director, OID; and 
the Directors of the National Center for Immunization and Respiratory 
Diseases, the National Center for Emerging and Zoonotic Infectious 
Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, 
and TB Prevention, CDC, concerning strategies, goals, and priorities 
for the programs and research within the national centers and monitor 
the overall strategic direction and focus of OID and the national 
centers.
    Matters To Be Discussed: The meeting will involve the presentation 
of a draft document being developed to advance CDC's infectious disease 
priorities. A subsequent meeting to solicit further discussion and 
input on the document from the board is currently scheduled for 
December 6, 2010 and will be announced at a future date.
    Requests for a copy of the draft document may be sent to 
ddidinput@cdc.gov prior to the teleconference.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Robin Moseley, CDC, OID, 1600 
Clifton Road, NE., Mailstop D-10, Atlanta, Georgia 30333, telephone 
(404) 639-4461.
    The Director, Management and Analysis Services Office, has been 
delegated the authority to sign the Federal Register notices pertaining 
to announcements of meetings and other committee management activities 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: October 22, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-27462 Filed 10-28-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.